Münch group describes coronavirus infection & potential therapies.
SARS-CoV-2 infection profile and therapeutic strategies.
Complementing conventional antibiotics: Frankfurt scientists reveal atomic details for one of Legionella’s enzymatic weapons and develop first inhibitor.
Researchers from IBC2 and BMLS have now made a major step to a better understanding of the genes causing ALS
19 Dec 2020
We strongly support the urge for a Pan-European strategy to contain #COVID19. More than 300 scientists signed a com… https://t.co/T2JRVLU43d
14 Dec 2020
Check out @NatureComms for exciting insights into the role of subunit LYRM6 within mitochondrial complex I, provide… https://t.co/jMIEhQakIG
19 Nov 2020
IBC2 Director @iDikic2 amongst the most influential scientists based on Clarivate’s #HighlyCited2020 list. It's the… https://t.co/89xX2FYf47
29 Oct 2020
Can Father Christmas Travel or Is Christmas Cancelled? IBC2 Director @iDikic2 on itv's Good Morning Britain… https://t.co/H1ff8lxEPK
FOLLOW ON TWITTER